Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Carbocisteine is an expectorant mucolytic used to alleviate respiratory diseases associated with increased mucus viscosity. Oral administration three times a day.
At the time of the last update, we found no published data on its excretion in breast milk.
Its high volume of distribution makes it unlikely to pass into breast milk in significant concentration.
The absorption from ingested mother's milk to the infant's plasma is hampered by a low oral bioavailability (Irish 2014, AEMPS 1998), with this being a reason for a nil or minimal plasma level in the infant, except in prematures or soon after birth when absorption would be higher.
It is a product that has only mild or few side-effects when used at normal dose. The manufacturer considers it probably compatible with lactation. (CINFA 2021)